Is it safe?
Can BLFS take a bad year?
BioLife Solutions, Inc. holds $82M more cash than debt, so a bad year is a question about profits, not about lenders.
$82M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Debt / equity
- 0.00×
Debt / equity
- Annualised volatility
- 51%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $0
- Cash and short-term investments
- $82M
- Net cash
- $82M
- EBITDA, trailing twelve months
- $4.1M
- Operating profit, trailing twelve months
- $3.0M
- Debt / equity
- 0.00×
- Total debt / EBITDA
- 0.00×
- Annualised volatilitytwo years of daily moves
- 51%
- Worst drawdown on file
- −85%
- Below its 52-week high
- −0.59%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #2 of 27 by Smart Score